L’Oréal Groupe is thrilled to announce a strategic research and development partnership with Tru Diagnostic, the foremost authority in epigenomics⁽¹⁾ testing. This collaboration aims to explore the connection between beauty indicators and changes in epigenomic markers, paving the way for groundbreaking advancements in the field of longevity.

Secures coveted Top 50 spot in Fortune and Korn Ferry’s 2025 compilation of global business powerhouses

Engages strategic partners to help support billions living with skin disease worldwide through knowledge, education, advocacy and best practice

L’Oréal Groupe achieves ninth consecutive CDP triple ‘A’ score, demonstrating its commitment to leadership and transparency in climate, forests and water security